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Abstract
We introduce quantitative polymerase chain reaction (qPCR) primers and multiplex end-point PCR primers modified by the
addition of a single ortho-Twisted Intercalating Nucleic Acid (o-TINA) molecule at the 59-end. In qPCR, the 59-o-TINA
modified primers allow for a qPCR efficiency of 100% at significantly stressed reaction conditions, increasing the robustness
of qPCR assays compared to unmodified primers. In samples spiked with genomic DNA, 59-o-TINA modified primers improve
the robustness by increased sensitivity and specificity compared to unmodified DNA primers. In unspiked samples,
replacement of unmodified DNA primers with 59-o-TINA modified primers permits an increased qPCR stringency. Compared
to unmodified DNA primers, this allows for a qPCR efficiency of 100% at lowered primer concentrations and at increased
annealing temperatures with unaltered cross-reactivity for primers with single nucleobase mismatches. In a previously
published octaplex end-point PCR targeting diarrheagenic Escherichia coli, application of 59-o-TINA modified primers allows
for a further reduction (.45% or approximately one hour) in overall PCR program length, while sustaining the amplification
and analytical sensitivity for all targets in crude bacterial lysates. For all crude bacterial lysates, 59-o-TINA modified primers
permit a substantial increase in PCR stringency in terms of lower primer concentrations and higher annealing temperatures
for all eight targets. Additionally, crude bacterial lysates spiked with human genomic DNA show lesser formation of non-
target amplicons implying increased robustness. Thus, 59-o-TINA modified primers are advantageous in PCR assays, where
one or more primer pairs are required to perform at stressed reaction conditions.
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Introduction
Optimization of a conventional quantitative polymerase chain
reaction (qPCR) assay requires consideration of a number of
different parameters such as primer design, primer concentration,
buffer composition, choice of polymerase and assay temperature
profile. Another fundamental challenge in the development of
qPCR assays for clinical diagnostics, e.g. for infectious diseases, is
the frequent need for highly multiplexed assays to cover all
relevant targets [1]. To ease the design of these multiplex qPCR
assays, it is beneficial if the primer concentrations can be reduced
without decreasing the qPCR efficiency in order to diminish the
likelihood of primer cross-reactivity and amplification of non-
target nucleotide sequences [2,3]. Likewise, the ability to increase
the annealing temperature or decrease the primer length without
negative impact on the qPCR efficiency is desirable in order to
diminish cross-reactivity of the qPCR primers and subsequent
problems with assay specificity [2,3]. Additionally, shortening the
primer lengths not only increases assay specificity, but also eases
primer design for clinical relevant targets by expanding the range
of possible target regions. These benefits are especially important
for targets with high mutation rates and when designing multi-
plexed qPCR assays.
Twisted Intercalating Nucleic Acid (TINA) is a novel group of
nucleic acid intercalating molecules (Figure 1) [4,5]. We have
previously shown that ortho-TINA (o-TINA) modified oligonucleo-
tides can improve the analytical sensitivity of a hybridization
capture assay without increasing the cross-reactivity [6]. For
optimal thermal stabilization of antiparallel duplex helixes, the o-
TINA molecules are added by covalent linkage at the 59- and/or
39- terminal ends of oligonucleotide sequences [6]. This is different
from artificial nucleic acids and nucleic acid mimics, such as
Locked Nucleic Acid (LNA) and Peptide Nucleic Acid (PNA)
which are placed internally as nucleotide substitutions in the
oligonucleotide sequence, and which are well known to inhibit the
DNA polymerase when placed in PCR primers [7,8]. We have
tested 59-o-TINA modified oligonucleotides as PCR primers, since
the observed improved analytical sensitivity in oligonucleotide
hybridization could potentially translate into improved efficacy of
the PCR reaction.
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a number of studies have introduced different modifications to the
PCR that can increase PCR efficiency [10–16]. To assess the
impact of different variables on PCR efficiency, qPCR is well
suited, as the PCR efficiency and product yield can be monitored
in real-time. An enhancement of the qPCR efficiency is either
demonstrated as an increase in qPCR efficiency for an assay under
suboptimal conditions [10–12,14] or as the amount of added stress
(reduced primer concentration, reduced annealing time, decreased
buffer salt concentrations or increased annealing temperature) that
will still allow for 100% qPCR efficiency for a qPCR assay
performing at 100% efficiency before the added stress [13]. A
number of small molecules (e.g. magnesium, low molecular amides
and formamide) have been shown to improve qPCR efficiency
under suboptimal qPCR conditions by globally decreasing buffer
stringency - but at the cost of target specificity [10–12,15,16].
Local improvements in primer annealing promise enhanced
qPCR efficiency and robustness, without the negative influence
on assay specificity.
To identify the potential effects of 59-o-TINA modifications of
PCR primers, we used a qPCR assay targeting the porA
pseudogene from Neisseria gonorrhoeae (N. gonorrhoeae) as a model
system [17]. Reaction conditions were optimized to allow for
optimal qPCR efficiency by unmodified DNA primers. The
optimal qPCR conditions were identified as the combination of
the maximum annealing temperature (Ta) and the minimum
primer concentration (Cprimers) allowing for 100% qPCR
efficiency. Based upon these optimal reaction conditions for
unmodified DNA primers, the qPCR assay was further in-
crementally stressed by increasing the Ta and decreasing the
Cprimers. The resulting qPCR efficiency under these stressed
conditions were tested for both the unmodified DNA primers
and the 59-o-TINA modified primers and are reported as part of
the present study. To ensure the applicability of our findings to
PCR assays in general, we have tested the impact of 59-o-TINA
modified primers on a previously published octaplex end-point
PCR assay, which is routinely used in clinical microbiology for
identification of human diarrheagenic Escherichia coli (E. coli) and
Shigella species [18].
Materials and Methods
Oligonucleotides
All oligonucleotides for the N. gonorrhoeae qPCR assay were
purchased from DNA Technology A/S (Risskov, Denmark) except
the unmodified match forward primer, which was purchased from
Eurofins (Ebersberg, Germany) on a 0.2 mmol synthesis scale. The
oligonucleotides for the diarrheagenic E. coli octaplex end-point
PCR assay were purchased from Eurofins (Ebersberg, Germany)
on a 0.2 mmol synthesis scale. All primers were synthesized on an
ABI-3900 with reverse phase high performance liquid chroma-
tography (RP-HPLC) purification and a final quality control by
mass spectrometry analysis before lyophilization. The ortho-TINA
amidite, used for the oligonucleotide synthesis, was synthesized as
reported in [6] and 59-o-TINA modified primers for research
purposes are available through Eurofins (Ebersberg, Germany).
The forward and reverse primer sequences used for amplifica-
tion of the porA pseudogene from N. gonorrhoeae were 59- CCG GAA
CTG GTT TCA TCT G -39 and 59- GTT TCA GCG GCA
GCA TTC A -39, respectively. The sequences of the 59-o-TINA
(Z) modified primers were 59- ZCC GGA ACT GGT TTC ATC
TG -39 and 59- ZGT TTC AGC GGC AGC ATT CA -39. Primer
sequences containing single nucleotide mismatches are included in
Table S1. The primer sequences used for the diarrheagenic E. coli
octaplex PCR assay were identical to the sequences published by
Brandal LT et al [18] and the sequences are listed below as 59-o-
TINA (Z) modified primers. The sequences for the unmodified
primers are identical, but without the Z modification. The primer
sequences were: aggR forward 59- ZGT ATA CAC AAA AGA
AGG AAG C -39, aggR reverse 59- ZAC AGA ATC GTC AGC
ATC AGC -39, eae forward 59- ZTC AAT GCA GTT CCG TTA
TCA GTT -39, eae reverse 59- ZGT AAA GTC CGT TAC CCC
AAC CTG -39, elt forward 59- ZTC TCT ATG TGC ATA CGG
AGC -39, elt reverse 59- ZCC ATA CTG ATT GCC GCA AT -39,
estAh forward 59- ZAT TTT TCT TTC TGT ATT GTC TT -39,
estAh reverse 59- ZCA CCC GGT ACA AGC AGG ATT -39, ipaH
forward 59- ZGT TCC TTG ACC GCC TTT CCG ATA CCG
TC -39, ipaH reverse 59- ZGC CGG TCA GCC ACC CTC TGA
GAG TAC -39, rrs forward 59- ZCC CCC TGG ACG AAG ACT
GAC -39, rrs reverse 59- ZAC CGC TGG CAA CAA AGG ATA -
39, stx1 forward 59- ZAA ATC GCC ATT CGT TGA CTA CTT
CT -39, stx1 reverse 59- ZTG CCA TTC TGG CAA CTC GCG
ATG CA -39, stx2 forward 59- ZCA GTC GTC ACT CAC TGG
TTT CAT CA -39 and stx2 reverse 59- ZGG ATA TTC TCC
CCA CTC TGA CAC C -39. The molecular weight of an o-TINA
monomer inserted into an oligonucleotide with all protecting
groups removed is 467.4 g/mol with an extinction coefficient of
24,090 at 260 nm.
The primers were delivered as lyophilized primers and
redissolved in double-distilled water to a stock concentration of
100 mM (based upon the reported UV measurements from the
oligonucleotide supplier) and left overnight at 4uC before use.
Primer concentrations were verified by triplicate UV-absorbance
measurements for each primer on a NanoDrop
TM 1000 (Thermo
Scientific Inc., Wilmington, NC, USA). The absorbance added by
the 59-o-TINA modification was not taken into account for the
determination of primer concentrations. For the diarrheagenic E.
coli octaplex PCR assay, a 10-fold standard mix of either all
unmodified or 59-o-TINA modified primers was made based upon
the UV-absorbance measurements from the NanoDrop
TM 1000.
Both standard mixes contained two mM of each primer, except for
the estAh primer pair for which four mM of each primer was used.
For the N. gonorrhoeae qPCR assay, the average primer concentra-
tion of the 19 unmodified primers from DNA Technology A/S
Figure 1. Ortho-TINA (o-TINA) modification attached to the 59-
end of the primer sequence.
doi:10.1371/journal.pone.0038451.g001
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primer concentration of the 20 59-o-TINA modified primers from
DNA Technology A/S was 96.2 mM (range 81.1 mMt o
110.8 mM). The average concentration of the match unmodified
forward primer for the N. gonorrhoeae qPCR assay from Eurofins
was 125.4 mM. The triplicate measurements on the NanoDrop
TM
1000 differed in average by 1.0% (range 0.1% to 2.5%). The
purity of the redissolved primers for the N. gonorrhoeae qPCR assay
was verified by Liquid chromatography – mass spectrometry (LC-
MS) by DNA Technology A/S (Risskov, Denmark). LC-MS
analyses for the N. gonorrhoeae qPCR assay primers were run on
a Thermo LCQ Fleet (Thermo Scientific Inc., Wilmington, NC,
USA) in negative mode and calculations were done in Promass for
Xcalibur (Novatia, LCC, Monmouth Junction, NJ). For LC-MS,
an ACE-3 C18-300, 5062.1 mm column (Advanced Chromatog-
raphy Technologies, Aberdeen, United Kingdom) was used with
the analytical conditions of 50uC; A gradient from 0-D% B over
20 minutes, A being water; 10 mM EDTA; 1% HFIPA; 0.1%
DIEA, B being water: acetonitrile (35:65); 10 mM EDTA; 1%
HFIPA; 0.1% DIEA and D being 25 for unmodified or 50 for 59-o-
TINA modified primers. The LC-MS indicates equal purity of
unmodified and 59-o-TINA modified primers for the N. gonorrhoeae
qPCR assay. To avoid introduction of bias by the correction of
concentrations without taking the absorbance added by the 59-o-
TINA modification into account, we used the primers for the N.
gonorrhoeae qPCR assay as delivered from the suppliers. This was
done as all match unmodified primers and almost all mismatch
unmodified primers were higher concentrated and with similar
purity compared to the 59-o-TINA modified primers and thereby
would favor the efficiency of the unmodified qPCR compared to
the reactions, where 59-o-TINA modified primers were applied.
Data for all primers for the N. gonorrhoeae qPCR assay are included
in Table S1.
Target DNA
As N. gonorrhoeae target, we used N. gonorrhoeae quantitated
bacterial DNA (cat.no. 08-924-000, Advanced Biotechnologies
Inc., Columbia MD, USA). For all experiments, we used lot
number A0705 containing 15,000 copies/mL determined by
qPCR targeting the B protein gene of N. gonorrhoeae by the
supplier. All target dilutions were done with double-distilled water,
on ice immediately before use. The nucleotide sequence of the N.
gonorrhoeae porA pseudogene is included as Figure S1 based on N.
gonorrhoeae NCCP11945, GenBank sequence CP001050.1, from
nucleotide 736237 to 737148 (912 nucleotides) equaling locus tag
NGK 0907 and protein ID ACF29586.1.
As target material for the diarrheagenic E. coli multiplex PCR,
we used eight clinical E. coli strains entailing one or more virulence
genes with the rrs gene (encoding 16S rRNA) as internal control.
The clinical strains were provided by Alice Friis-Møller (De-
partment of Clinical Microbiology, University Hospital of
Hvidovre, Copenhagen, Denmark). The clinical strains were
identified according to Standard Operating Procedures and are
presented by name and virulence factor(s) in brackets: fr1368
(ipaH), 55989 (aggR), D2259 (estAh), D2260 (elt), D2168 (estAh, elt),
D2432 (stx2), D3522 (stx1), D2188 (eae, stx1, stx2). Bacterial DNA
was extracted after suspension of approximately half a plated
bacterial colony in 100 mL of double distilled water by boiling for
15 minutes and centrifugation at 14,500 rpm for one minute in an
Eppendorf MiniSpin plus (Eppendorf Nordic Aps, Hørsholm,
Denmark). All target dilutions were done with double-distilled
water, on ice immediately before use.
Preparation of Genomic DNA for Spiking Experiments
Human genomic DNA was purified from the human hepatoma
cell line Huh-7.5 [19] provided by Jens Bukh (University of
Copenhagen, Denmark) or the leukocyte fraction from whole
blood discarded for clinical use provided by the Department of
Clinical Immunology - Blood Bank (Rigshospitalet, Denmark)
using NucleoBondH AXG columns and the NucleoBondH buffer
set IV with addition of buffer G1 (Macherey-Nagel GmbH,
Du ¨ren, Germany). The protocol was taken from ‘‘Genomic DNA
and total RNA purification protocols’’ of December 2010, revision
4 (Macherey-Nagel GmbH, Du ¨ren, Germany) following the
‘‘Protocol for NucleoBondH CB 500’’ for ‘‘Isolation of genomic
DNA from blood and cell cultures’’. Eluation was done in double-
distilled water. The concentration of dsDNA (dsDNA-50) was
measured in triplicate on the NanoDrop
TM 1000 (Thermo Fisher
Scientific Inc., Wilmington, USA) and the purified DNA was
stored at –20uC until use. The concentration of dsDNA from the
Huh-7.5 cell line was 927 ng/mL (range 921 ng/mL to 933 ng/
mL) with a purity in terms of A260/A280 of 1.85 (range 1.78 to
1.91), whereas the DNA isolated from whole blood leukocytes had
a concentration of 254 ng/mL (range 244 ng/mL to 262 ng/mL)
with an A260/A280 purity of 1.88 (range 1.85 to 1.90).
Genomic DNA from the E. coli ATCC 25922 strain was isolated
from bacteria harvested in the exponential growth phase using
NucleoBondH AXG columns and the NucleoBondH buffer set III
(Macherey-Nagel GmbH, Du ¨ren, Germany). The protocol was
based on ‘‘Genomic DNA and total RNA purification protocols’’,
December 2010, revision 4 (Macherey-Nagel GmbH, Du ¨ren,
Germany) following the protocol for ‘‘Isolation of genomic DNA
from bacteria’’ with the following recommended modifications.
For cell disruption 10 mg of lysozyme was added and incubation
time was set to one hour. Eluation was done in double-distilled
water. The concentration of dsDNA was measured to 1,098 ng/
mL on the NanoDrop
TM 1000 (Thermo Fisher Scientific Inc.,
Wilmington, USA) with an A260/A280 of 1.94. dsDNA was stored
at 220uC until use.
Quantitative PCR Protocol
qPCR was performed in a 10 mL reaction volume using in-
house 1x Euro-Optima buffer (10.4 mM Tris-HCl, 56.8 mM
Trizma-base, 16.1 mM (NH4)2SO4, 30 mM NaCl, 0.01%
Tween80), 3 mM MgCl2, 0.08% Bovine Serum Albumine (non-
acetylated), 16SYBR Green I (cat.no. 11988131001, Roche
Diagnostics A/S, Hvidovre, Denmark), 0.2 mM of each dNTP
(a mixture of dTTP and dUTP was applied as 0.066 mM dTTP
and 0.133 mM dUTP), 0.25 Unit of Uracil DNA Glycosylase
(cat.no. EN0361, Fermentas GmbH, St. Leon-Rot, Germany), 1
Unit KAPA2G Robust HS (KapaBiosystems, Cape Town, South
Africa) in an AbgeneH SuperPlate
TM 96-well PCR plate (AB gene,
Epsom, United Kingdom) sealed with Optically clear, adhesive
MicrosealH ‘B’ Film (BioRad Laboratories, Copenhagen, Den-
mark). All qPCR setups were performed manually on ice.
qPCR was performed on the CFX96
TM Real-Time System
(BioRad Laboratories, Copenhagen, Denmark) utilizing the
following cycling conditions: UNG treatment for 10 minutes at
40uC; UNG inactivation and Hot-Start polymerase activation for
10 minutes at 95uC; 45 cycles of denaturation at 95uC for 10
seconds; annealing at different temperatures for 5 seconds; and
elongation at 72uC for 5 seconds and plate read. A melting curve
profile was collected consisting of 10 seconds at 95uC and a melt
curve from 65uCt o9 0 uC with 0.5uC increments per 5 seconds and
the samples were cooled for 10 minutes at 10uC. The length of the
qPCR amplicon was 102 base pairs (bp).
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100, 150, 200, 300, 400, 600 and 800 nM of each primer. The
primer ‘‘chessboard titration’’ included the combinations of 100,
200 and 400 nM of each primer. For efficiency curves, we used
a three-fold dilution series in triplicates starting from 10,000
copies/well down to 14 copies/well and a negative control
(double-distilled water) in triplicate. In all other experiments, the
quantification cycle (Cq, previously known as threshold cycle, Ct)
values were determined using triplicate measurements of 1,000
copies of target per well with negative control in triplicate utilizing
the highest relevant primer concentration. Spiked samples were
either added as 10 ng or 100 ng of genomic DNA from E. coli
ATCC 25922 or the Huh-7.5 cell line per well, which was also
added to the negative controls. Annealing temperatures were
either 58.0, 60.0, 62.0, 64.0, 66.0, 68.0, 70.0 or 72.0uC.
Frequently used annealing temperatures were 60.0uC for un-
modified DNA primers and 66.0uC for 59-o-TINA modified
primers or a temperature gradient of 60.0 (used for negative
controls), 61.0, 63.0, 65.9, 69.5, 72.5, 74.2 and 75.0. In
experiments with different annealing times, the annealing time
was set to 5, 10 and 30 seconds at 66.0 or 70.0uC to evaluate the
influence of annealing time on qPCR efficiency. Specifications of
reaction conditions for each experiment can be found in the figure
legends and the supplementary figure files.
End-point Multiplex PCR Protocol and Gel
Electrophoresis
The octaplex end-point PCR targeting diarrheagenic E. coli was
performed in a 50 mL reaction volume in an Eppendorf twin.tec
96-well PCR plate (Eppendorf Nordic Aps, Hørsholm, Denmark)
sealed with Optically clear, adhesive MicrosealH ‘B’ Film (BioRad
Laboratories, Copenhagen, Denmark). 1x Qiagen Multiplex PCR
Master Mix (Qiagen Denmark, København Ø, Denmark) was
mixed with a primer mix of either unmodified primers or 59-o-
TINA modified primers to a final concentration of 200 nM of
each primer, except for the estAh primer pair for which a final
concentration of 400 nM of each primer was used as published by
Brandal LT et al [18]. Two mL of boiled bacterial supernatant was
added as the maximal target concentration and lower target
concentrations were prepared as 10-fold dilution series to a 10,000
dilution of the maximal target concentration and a negative
control (double-distilled water). All PCR setups were performed
manually on ice.
The octaplex PCR was performed on a SensoQuest Labcycler
(SensoQuest GmbH, Go ¨ttingen, Germany) utilizing the following
cycling conditions: Hot-Start polymerase activation for 15 minutes
at 95uC; 30 cycles of denaturation at 94uC for 30 seconds;
annealing at 57uC for 30 seconds; and elongation at 72uC for 30
seconds and a final extension step at 72uC for 10 minutes. In the
published PCR program from Brandal LT et al. [18], the applied
annealing time and elongation time is 90 seconds each. The
lengths of the PCR amplicons were 190 bp for estAh, 254 bp for
aggR, 283 bp for stx2, 322 bp for elt, 370 bp for stx1, 401 bp for rrs,
482 bp for eae and 619 bp for ipaH. Amplicons were visualised on
3% agarose gel stained by 1x Gel Red (Biotium Inc, Hayward,
CA, USA) with GeneRuler 100 bp Plus DNA Ladder (Fermentas
GmbH, St. Leon-Rot, Germany). Pictures were taken on an UV-
table with a fixed illumination time of 0.120 seconds.
For evaluation of the octaplex PCR in an E. coli DNA free PCR
buffer, we used our in-house 1x Euro-Optima buffer system as
described for the N. gonorrhoeae qPCR assay with unaltered PCR
program except for an annealing temperature of 60uCi na5 0mL
reaction volume. For crude bacterial lysates spiked with human
genomic DNA, we used one mg of human genomic DNA isolated
from leukocytes per well. Evaluation of different primer concen-
trations was done by dilution of the two primer standard mixes
containing either unmodified primers or 59-o-TINA modified
primers. All dilutions of primer mixes contained equal amounts of
each primer, except for the estAh primer pair for which the double
concentration of each primer was used. Final primer concentra-
tions of 50, 100, 150, 200, 300 and 400 nM of each primer (double
for estAh primers) were tested for a crude bacterial lysate from
strain D2259, a 10-fold dilution of strain D2168 and D3522 and
a 100-fold dilution of strain 55989 and D2260. Final primer
concentrations of 25, 50, 100, 150, 200 and 300 nM of each
primer (double for estAh primers) were tested for a 10-fold dilution
of strain D2432 and D2188, whereas final primer concentrations
of 12.5, 25, 50, 100, 150 and 200 nM of each primer (double for
estAh primers) were tested for a 100-fold dilution of strain fr1368.
For evaluation of the annealing temperature, a temperature
gradient of 55.0, 56.6, 57.9, 59.4, 60.8, 62.3, 63.7, 65.2, 66.6, 68.1,
69.5 and 71.0uC was tested for a crude bacterial lysate from strain
D2168 and a 10-fold dilution of strain 55989, whereas a temper-
ature gradient of 60.0, 61.5, 62.9, 64.4, 65.8, 67.3, 68.7, 70.2,
71.6, 73.1, 74.5 and 76uC was tested for a 10-fold dilution of strain
D2188. As the PCR primers for the ipaH gene worked extremely
well, a temperature gradient of 65.0, 66.5, 67.9, 69.4, 70.8, 72.3,
73.7, 75.2, 76.6, 78.1, 79.5 and 81.0uC for 60 seconds and with
the omission of the 30 seconds of elongation at 72uC was tested for
a 100-fold dilution of strain fr1368.
Data Analysis
For data analysis of the N. gonorrhoeae qPCR assay we used the
Bio-Rad CFX Manager software, Version 1.1. Raw data were
baseline subtracted with curve fit and the single threshold
method was used for Cq determinations. The single threshold
defined by the software was checked for each plate to be in the
middle part of the exponential phase of all amplification curves,
and if necessary corrected to the midmost part of the exponential
phase. Inter-assay normalization of the Cq determinations were
based on triplicate measurement of a control, holding 800 nM of
each unmodified primer at 61uC. For each experiment with
inter-assay normalization, the threshold was adjusted to be within
the middle part of the exponential phase, allowing a mean Cq of
25.11 for the control with a standard deviation (SD) of 0.1 for
the experimental controls on each of the four inter-assay
normalized plates.
qPCR efficiency was calculated as 10
21/slope–1 with the
logarithm of the template concentration on the x axis and the Cq
plotted on the y axis. A qPCR efficiency of 100% thereby
indicates that the amount of PCR product doubles with each
cycle.
The melting curves for all samples were checked prior to data
analysis. Samples with changes in melting point or major changes
in the melting curve profile were excluded from the data analysis.
This was done for all samples, except for the experiments with
spiked samples, as the visualization of melting curves changes is
necessary for the evaluation of these experiments. Negative
control melting curves were analyzed to rule out contamination.
Exclusion of outliers was held to a minimum, and was only done
if single reactions in the triplicate measurements differed
significantly (defined as mean +/21.966SD). An asterisk in the
supplementary data files indicates these excluded outliers.
Melting points were defined as the peak of the first derivative.
The melting point was a half to one uC higher for all qPCR
amplicons modified by 59-o-TINA molecules compared to
unmodified DNA amplicons.
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59-o-TINA Modified Primers Improved qPCR Efficiency
The unmodified DNA primers were found to allow for a qPCR
efficiency of 100%, when a Cprimers of 400 nM or more was used
at a Ta of 66uC or less (Figure 2). A similar (100%) qPCR
efficiency at 66uC was obtained with a 59-o-TINA modified
Cprimers of 200 nM or more (Figure 2). For both unmodified and
59-o-TINA modified primers, the qPCR efficiency decreased
equally as Cprimers were further incrementally decreased, as
expected (Figure 2). To address the effect of different Cprimers on
the quantification cycle threshold (Cq) [20], we compared
unmodified and 59-o-TINA modified Cprimers in the range 50 to
800 nM and a Ta from 58 to 72uC with 1000 copies of target per
reaction (Figure S2). At all Cprimers and Ta, the Cq of 59-o-TINA
modified primers was similar to or lower compared to unmodified
primers. Cq indisputably increased at lower Cprimers and in-
creasing Ta for both unmodified and 59-o-TINA modified primers.
The difference in Cq between the unmodified primers and the 59-
o-TINA modified primers indisputably increased in favor of the 59
o-TINA modified primers as Ta was increased towards 72uC, e.g.
at 68uC, a DNA Cprimers of 800 nM reached the minimal Cq
level, whereas a 59-o-TINA Cprimers of 300 nM or higher reached
the same Cq (Figure S2). As the Ta increased from 58uC towards
72uC, we observed that the minimal Cq level was lowered. This
was caused by a decrease in Cq threshold level, since the
background signals of the assay decreased by increasing Ta and
thereby increased the signal-to-noise ratio of the assay (Figure S2).
We used temperature gradient experiments with inter-assay
normalization to evaluate the effect of Ta on Cq at different
Cprimers for both unmodified and 59-o-TINA modified primers
(Figure 3). For unmodified primers at Cprimers of 400 nM or more,
the minimal Cq was observed at a Ta below 69uC (Figure 3a). For
59-o-TINA modified primers, a similar Cq was observed at
Cprimers of 200 nM or more and at a Ta below 72uC (Figure 3b).
We conclude that 59-o-TINA modified primers compared to
unmodified DNA primers sustain a qPCR efficiency of 100% at
significantly lower Cprimers, higher Ta and combinations of both.
No Difference in qPCR Specificity between Unmodified
and 59-o-TINA Modified Primers
To compare the specificity (potential for cross-reactivity) of
unmodified DNA and 59-o-TINA modified qPCR primers with
single nucleotide mismatches, we applied a Ta for each Cprimers
that allowed for a qPCR efficiency of 100% for match primers. For
each Cprimers, it was demonstrated that an increase in Ta would
reduce the qPCR efficiency below 100%, implying that the assay
was performed at the most stringent conditions that allowed for
a qPCR efficiency of 100% with the match primers (Table S2).
Single nucleotide mismatches were introduced in both primers at
59-, central and 39- positions in the primers to evaluate the effect of
the 59- terminally placed o-TINA molecule on the mismatch
discrimination of the primers. The changes in Cq observed by
introduction of single nucleotide mismatches in the primers were
equal for both unmodified and 59-o-TINA modified primers
(Table S2 and Table S3). As expected, Cq increased significantly,
when single nucleotide mismatches were introduced in the 39- part
of the primers and diminished towards the 59- end of the primers
(Table S2). As expected, the increase in Cq was enlarged, when
the qPCR efficiency for match primers dropped below 100%. All
Cprimers for unmodified and 59-o-TINA modified primers with
single nucleotide mismatches were found to increase the Cq
equally (Table S2 and Table S3). In conclusion, unmodified and
59-o-TINA modified primers equally impacted the discrimination
of single nucleotide mismatches located within the primer
sequences.
59-o-TINA Modified Primers Increased the Robustness
When qPCR Samples were Spiked with Human or
Bacterial Genomic DNA
As 59-o-TINA modified primers allow for higher Ta and lower
Cprimers in a qPCR assay without compromising the cross-
reactivity of the primers, we would expect that primer cross-
reactivity with non-target sequences in clinical samples would
diminish compared to unmodified primers. Figure 4 indeed
demonstrates that addition of 10 or 100 ng of human genomic
DNA to the assay hampered accurate qPCR efficiency determina-
tions for unmodified primers, whereas 59-o-TINA modified
primers were left unaffected. For non-spiked samples, 200 nM of
unmodified primers at a Ta of 60.0uC resulted in a qPCR
efficiency of 100%, whereas samples spiked with human genomic
DNA resulted in loss of target dilution linearity (qPCR efficiencies
far above 100% in combination with very low coefficient of
determination (R
2) for data used for efficiency curve determina-
tions) and loss of melting curve uniformity at especially lower
target concentrations for the unmodified primers, which would
normally lead to exclusion of the data before efficiency curve
determinations (Figure 4). However, we have included these data
to show the difference in qPCR efficiency and robustness between
unmodified and 59-o-TINA modified primers in samples spiked
with human genomic DNA. In contrast, 200 nM of 59-o-TINA
modified primers at a Ta of 66.0uC spiked with equal amounts of
human genomic DNA only lead to a minor parallel shift in Cq of
the target dilution series, due to an increased background and
thereby threshold of the assay. Furthermore, only minor changes
in the melting curve profiles were observed (Figure 4). To verify
the results, we replicated the experiment, spiking the samples with
genomic DNA purified from Escherichia coli and observed similar
results (Figure S3). The non-target cross-reactivity of the un-
modified primers could be eliminated by increasing Cprimers to
400 nM and Ta to 66.0uC (Figure S3).
Prolongation of Annealing Times Changed the qPCR
Efficiency Equally for Unmodified and 59-o-TINA Modified
Primers
In the design of the present study, we performed the qPCR
assays utilizing a relatively short annealing time to increase the
stringency of the assay. As expected, prolongation of the annealing
time, while keeping the Ta and Cprimers constant, increased the
qPCR efficiency, but at the cost of assay stringency (Figure S4).
The influence of annealing time on stringency was observed to be
equal for both unmodified and 59-o-TINA modified primers, as
expected (Figure S4).
The Unmodified qPCR Primers Showed Equal Limiting
Effect on Cq, whereas for 59-o-TINA Modified Primers the
Reverse Primer Limited Cq
The limiting effect on Cq by different primer concentrations
was evaluated by primer ‘‘chessboard titration’’ (Table S4). For
unmodified primers, no significant difference in Cq was observed
when equal concentrations of forward and reverse primer were
limiting the qPCR assay. For 59-o-TINA modified primers the
reverse primer was the limiting primer (Table S4). To ease the
comparison of different primer concentrations throughout the
study, we used equal concentrations of forward and reverse
primers in all other experiments.
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Optimal PCR Program Length in Octaplex End-point PCR
As seen in Figure 5a, the unmodified primers and 59-o-TINA
modified primers amplified the three specific targets in the D2168
strain with equal analytical sensitivity using the published PCR
program from Brandal LT et al. [18]. For both the unmodified
and 59-o-TINA modified primers an amplification product for the
rrs internal control gene was amplified in the negative control and
the unmodified PCR primers contrary to the 59-o-TINA modified
primers also amplified a non-specific product with a mass below
the estAh amplification product in the two highest target
concentrations. As the PCR program length was shortened by
60 minutes from a total PCR program length of approximately
130 minutes to approximately 70 minutes, all three specific
amplicons could still be observed with similar analytical sensitivity
for the 59-o-TINA modified primers, whereas an estAh amplifica-
tion product could not be detected by the unmodified primers (red
box in Figure 5b). Using the faster PCR program, amplification of
the rrs internal control gene in the negative controls was still
observed. To ensure that both PCR programs worked equally well
for the remaining five targets, we tested the remaining seven
bacterial strains. The D2259 strain, which entail the estAh target
confirmed the observations for the D2168 strain, whereas the
remaining strains showed no difference in amplification, analytical
sensitivity or non-specific amplification between unmodified and
59-o-TINA modified primers connected to the length of the PCR
program (Figure S5). For all strains and both unmodified primers
and 59-o-TINA modified primers, the rrs internal control gene was
amplified in the negative control. We therefore changed the PCR
buffer to our in-house Euro-Optima buffer system and for all eight
bacterial strains the negative controls became negative. Un-
fortunately the Euro-Optima buffer system gave rise to a non-
specific product for the unmodified primers with a mass equaling
the mass of the stx2 amplification product in strain 55989, D2259,
D2260 and D3522 (Figure S5). In the remaining experiments, we
continued to use the Qiagen Multiplex PCR Master Mix
containing traces of genomic E. coli DNA, but not the virulence
factors.
59-o-TINA Modified Primers Increased the Robustness of
the Octaplex End-point PCR on Spiked Samples
Four strains (fr1368, 55989, D2168 and D2188) collectively
containing all eight targets were spiked with one mg of human
genomic DNA isolated from the leukocyte fraction of whole blood.
As seen in Figure 5c for strain D2168, all specific targets were
amplified with a tendency towards lower analytical sensitivity for
both unmodified primers and 59-o-TINA modified primers. For all
four bacterial strains, the spiking induced the amplification of
a non-specific product with a size equaling the ipaH product and
the non-specific product was marked in the spiked negative
controls and highly diluted spiked bacterial strains (red boxes in
Figure S6). Especially the unmodified DNA primers lead to the
formation of the non-specific product, which could be detected at
10-fold to 100-fold higher bacterial target concentrations com-
pared to the 59-o-TINA modified primers (red boxes in Figure 5c
and Figure S6). Based on these results we conclude that 59-o-TINA
modified primers were less prone to off-target amplification
compared to unmodified primers, increasing the robustness for
amplification of spiked targets in the octaplex end-point PCR.
59-o-TINA Modified Primers Amplified the Octaplex End-
point PCR at Reduced Primer Concentrations and
Increased Annealing Temperatures
As for the N. gonorrhoeae qPCR assay, we compared the effect of
lower Cprimers and increasing Ta for unmodified primers and 59-o-
TINA modified primers in the octaplex end-point PCR assay with
subsequent gel electrophoresis. Figure 5d illustrates the difference
in detection of PCR products between unmodified and 59-o-TINA
modified primers at lower Cprimers for the elt, estAh and rrs genes in
D2168. For the elt, estAh, rrs, partly stx1 (D2188) and stx2 targets,
we observed a PCR product at half the Cprimers with 59-o-TINA
modified primers compared to unmodified primers, whereas we
for the aggR, eae, ipaH and partly stx1 (D3522) targets observed
a stronger band at the lowest Cprimers that formed PCR products
implying that 59-o-TINA modified primers allow amplification at
lower Cprimers compared to unmodified primers (Figure S7).
Figure 2. Efficiency curves for unmodified and 59-o-TINA modified primers. All experiments were conducted at an annealing temperature
(Ta) of 66.0uC and primer concentrations (Cprimers) of unmodified and o-TINA modified primers were compared on the same plate. The melting
curves corresponding to the amplification curves used for efficiency curve determination are included for the lowest Cprimers that allows an
efficiency of 100% for unmodified and 59-o-TINA modified primers.
doi:10.1371/journal.pone.0038451.g002
Figure 3. Comparison of unmodified and 59-o-TINA modified primer concentrations on a temperature gradient. (a) Unmodified DNA
primer concentrations from 50 nM (X) to 800 nM (.). (b) 59-o-TINA modified primer concentrations from 50 nM (e) to 800 nM (=). Each threshold
cycle (Cq) determination is presented as mean +/2 standard deviation (SD) established by triplicate measurements with 1000 copies per well of
target. Inter-plate normalization was based on triplicate measurements using 800 nM of unmodified primers and an annealing temperature of 61.0uC
(mean Cq for normalization was 25.11 with a SD of 0.1 on each plate).
doi:10.1371/journal.pone.0038451.g003
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and 59-o-TINA modified primers, respectively, on a temperature
gradient for strain D2168 entailing the elt, estAh and rrs target
genes. For all three targets 59-o-TINA modified primers allowed
visual detection of target amplification at Ta increased by 1.5uCt o
above 3.0uC compared to amplification by unmodified primers.
Similar results were obtained for Ta evaluation for strain fr1368,
55989 and D2188 collectively, covering the remaining six targets
when 59-o-TINA modified primers were compared to unmodified
primers. Thus, 59-o-TINA modified primers increased the Ta for
all targets in the octaplex end-point PCR compared to unmodified
primers (Figure S8).
Discussion
In establishing a qPCR assay, the optimal balance between
assay component concentrations and cycling conditions must be
identified. In general, a trade-off must be made between sensitivity
and specificity - high primer concentrations and low annealing
temperature will maximize analytical sensitivity and qPCR
efficiency at the cost of cross-reactivity and specificity and vice
versa. In any qPCR system, a threshold can be found, where
further reduction in primer concentration or further increase in
annealing temperature will result in a reduction in PCR efficiency.
In this study, we demonstrate the effect of an o-TINA modification
on the 59- position of the qPCR primers. In our model qPCR
system, the 59-o-TINA modification enables the use of half the
primer concentration and simultaneously allowed for an additional
increase in annealing temperature (of 3uC) compared to un-
modified primers without reducing the qPCR efficiency. The
present findings are likely to be generic to all 59-o-TINA modified
primers as they were verified for all 16 primers amplifying eight
targets in an octaplex end-point PCR and are in concordance with
our previous findings that o-TINA modifications at the 59- and 39-
terminal ends of an oligonucleotide increase the melting point
(Tm) and the analytical sensitivity of a hybridization capture assay
significantly [6].
In the present study, we find that single nucleotide mismatches
in the primer sequences alter Cq equally for unmodified and 59-o-
TINA modified primers, when unmodified and 59-o-TINA
modified primers are compared at the most stressed reaction
condition that allows for a 100% qPCR efficiency. This clearly
indicates that the 59-o-TINA modified primers do not compromise
the specificity of the qPCR compared to unmodified primers.
Similar results have previously been shown for LNA containing
primers, whereas Zip Nucleic Acid (ZNA) containing primers have
been found to diminish the discrimination of non-target DNA
controls [14]. We have previously shown that TINA molecules
diminish the change in Tm by single nucleotide mismatches, when
they are placed directly adjacent to non-complementary nucleo-
base pairs [6,21], but that TINA molecules have no influence on
the change in melting point by single nucleotide mismatches, when
they are not placed directly adjacent to non-complementary
nucleobase pairs. We therefore propose that o-TINA molecules
influence the stacking of the first couple of adjacent nucleobases in
the primer sequence, but does not influence the overall
hybridization and cross-reactivity of the primers, whereas LNA
molecules alters the conformation of the nucleotide helix from a B-
DNA to an A-DNA like conformation [22], and ZNA containing
primers diminish the overall backbone repulsion depending on the
area of the primer they cover [23].
Figure 4. Comparison of primers in samples spiked with human genomic DNA (gDNA). (a-c) unmodified DNA primers and (d-f) 59-o-TINA
modified primers. Each # on the efficiency curves represents one threshold cycle (Cq) determination on an amplification curve with a corresponding
melting curve, reported as the first derivative. Cq determinations highlighted in red would normally have been excluded based on the amplification
curve and melting curve evaluation. (a, d) Unspiked samples. (b, e) All samples and negative controls spiked with 10 ng gDNA. (c, f) All samples and
negative controls spiked with 100 ng gDNA. A uniform primer concentration of 200 nM was used in all samples and negative controls. The annealing
temperatures for unmodified and o-TINA primers were 60.0uC and 66.0uC, respectively.
doi:10.1371/journal.pone.0038451.g004
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TINA molecule within the DNA double helix is currently
available, we hypothesize the following mechanism: Due to the
weaker hydrogen binding, adenine and thymine rich regions of
dsDNA are more likely to be accessible for hybridization
compared to guanine and cytosine rich regions. This fact in
combination with the fact that the TINA molecules seem to
intercalate equally well in-between all nucleobases, make us
Figure 5. Amplification of an octaplex end-point PCR by unmodified primers and 59-o-TINA modified primers. Data are shown for the
D2168 strain entailing the rrs (401 bp), elt (322 bp) and estAh (190 bp) genes. (a) PCR program length of approximately 130 minutes, with a 10-fold
target dilution series on crude bacterial lysate to 10,000-fold dilution and a negative control (NC) for unmodified primers and 59-o-TINA modified
primers. (b) Set-up identical to (a), but with a PCR program length of approximately 70 minutes. The red box highlights the lack of amplicons for the
estAh gene with unmodified primers. (c) Set-up identical to (b), but additionally spiked with one mg of human genomic DNA per well. Red boxes
highlight a non-specific amplicon with a size equaling the ipaH product. (d) 10-fold dilution of strain D2168 with different primer concentrations
(Cprimers) of 50, 100, 150, 200, 300 and 400 nM for unmodified primers and 59-o-TINA modified primers. Red lines are placed at the minimum
Cprimers for unmodified primers. (e, f) Increasing annealing temperatures (Ta) of 55.0, 56.6, 57.9, 59.4, 60.8, 62.3, 63.7, 65.2, 66.6, 68.1, 69.5 and 71.0uC
on crude bacterial lysate for unmodified primers (e) and 59-o-TINA modified primers (f). Red lines are placed at the maximum Ta for unmodified
primers. In (a-c, e, f), a Cprimers of 200 nM was used for each primer, except the estAh primers for which 400 nM of each primer was used. The PCR
program with a length of approximately 70 minutes was used in (b-f).
doi:10.1371/journal.pone.0038451.g005
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in the less stable adenine and thymine rich regions. Due to the
terminal position, the pyrene moiety of the 59-o-TINA molecule is
likely to be stacking onto the terminal nucleobase pair with the
phenyl moiety shifted towards the major groove and phosphate
backbone of the oligonucleotide. This is supported by structure
models and in-house unpublished PCR data.
As 59-o-TINA modified primers allow for higher annealing
temperatures and lower primer concentrations, we observed an
increase in qPCR as well as end-point PCR robustness for samples
spiked with genomic DNA from human or bacteria. The observed
effects may partly be due to the higher annealing temperatures,
which diminish the likelihood of cross-reactivity between specific
and non-specific targets and amplification of non-target sequences
and subsequent changes in the melting curve profiles. But as the
target dilution linearity was sustained even at low primer
concentrations for 59-o-TINA modified primers, it also demon-
strated that the 59-o-TINA modified primers are still annealing to
their specific targets in the presence of substantial amounts of non-
specific targets. This is in contrast to the unmodified primers, for
which increasing amounts of non-specific target amplification was
observed resulting in loss of target dilution linearity. Likewise, the
unmodified primers in the octaplex end-point PCR showed higher
tendency to cross-reactivity at especially lower target concentra-
tions compared to 59-o-TINA modified primers for both samples
spiked with human genomic DNA and when the buffer-system was
changed to lesser stringent reaction conditions. In both cases,
cross-reactivity was exclusively observed for the lesser stressed
primer pairs (either the ipaH or stx2 primer pairs) and was
distinctly stronger for unmodified primers compared to 59-o-TINA
modified primers. The observed improved robustness for 59-o-
TINA modified primers may especially be beneficial when
amplifying DNA directly from complex clinical samples and in
the optimization of multiplex qPCR assays, in which the
robustness of a single qPCR reaction limits the overall stringency
of the multiplex qPCR assay. In general, added robustness is
a major benefit contributed by modifying DNA oligonucleotides
with nucleic acid intercalating molecules, as oligonucleotide
stability and hybridization power is significant improved.
For the octaplex end-point PCR targeting diarrhoeagenic E.
coli, we have demonstrated that the present buffer system from
Qiagen entails traces of genomic DNA from E. coli leading to
amplification of the rrs internal control gene from E. coli in the
negative controls. This is a well-known problem for polymerases
produced in bacterial systems and adds in this case to the draw-
backs of the current octaplex end-point PCR assay for detection of
diarrhoeagenic E. coli [24]. Although the 59-o-TINA modified
primers improved efficiency of the eight individual targets in the
octaplex PCR, we still observed very diverse analytical sensitivity,
optimal primer concentrations, optimal annealing temperatures
and tendency to non-specific amplification for the eight primer
pairs. Even though the introduction of 59-o-TINA modified
primers solved the biggest clinical draw-back of the assay in terms
of the very long PCR program length, the uniformity of the assay
still needs to be improved. The lack of assay uniformity illustrates,
why multiplex assays should be designed following a predefined set
of parameters and not just compost of a number of preexisting
singleplex assays.
We propose that the effects by 59-o-TINA modification of
primers observed in the present study are likely to be applicable to
design of PCR assays in general, as the changes in PCR reaction
conditions applied in this study and the resulting impact on PCR
efficiency and robustness follows predictable and well-established
rules within basic PCR assay design.
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